Search results
Neuralink is a company that aims to create a generalized brain interface to restore autonomy to those with unmet medical needs and unlock human potential. Learn about their implantable, wireless, and biocompatible device, their surgical robot, and their patient registry for clinical trials.
- Careers
Discover your future at Neuralink, where we lead the...
- Mailing List
Subscribe to Neuralink to receive the latest updates and...
- Series C Funding Round Announcement
Neuralink has spent the last four years developing the first...
- Husbandry Refinement
Comfortable housing for sheep, therefore, includes a variety...
- Keep Reading
Neuralink is developing a brain-computer interface to enable...
- Neuralink's Approach to Animal Welfare
At Neuralink, we are absolutely committed to working with...
- Championing The 3 Rs
The “3 Rs alternatives” refers to the refinement, reduction,...
- Careers
May 9, 2024 · Neuralink is a company founded by Elon Musk in 2016 that’s developing a brain-computer interface called “the Link,” which is a surgically embedded neural-chip implant designed to decode and stimulate brain activity. Neuralink implanted its first device in a patient’s brain in January 2024.
Neuralink Corp. [4] is an American neurotechnology company that has developed, as of 2024, implantable brain–computer interfaces (BCIs), and is based in Fremont, California. Founded by Elon Musk and a team of seven scientists and engineers, Neuralink was launched in 2016 and was first publicly reported in March 2017.
Jun 9, 2024 · Neuralink is a neurotechnology company founded by Elon Musk in 2016. It aims to enable communication between the human brain and computers. Neuralink implants a chip into the skull and several threads directly into the brain to monitor and stimulate brain activity.
May 22, 2024 · Known as a brain-computer interface, or BCI, it decodes intended movement signals in the brain and translates them into computer commands. Arbaugh just has to think about moving a cursor on...
Jan 30, 2024 · Neuralink’s current trial, named the The PRIME Study, is aimed at providing individuals with quadriplegia the ability to control external devices with their thoughts.
Everything you need to know about Neuralink - BBC Science Focus Magazine.